ALK and large cell neuroendocrine carcinoma: ALK rearrangements are commonly identified in lung adenocarcinoma; LCNEC with ALK rearrangements is exceedingly rare and often associath-grade pathology, advanced-stage presentation, and poor prognosis (Zheng et al., 2018; Shaw et al., 2013).